Research News

Fatty acid oxidation inhibits breast cancer cells in animal models

Fatty acids oxidation (FAO) confers Epithelial-to-mesenchymal transition causing enhanced tumorigenicity and drug resistance to cancer cells. This study by N2CR member A/Prof Tam Wai Leong and his team demonstrates that pharmacological inhibition of FAO could block breast cancer cells in animal models. Hence, the addiction to specific metabolic pathways during distinct steps of cancer progression may be exploited to target specific cell states and opens up new avenues for antimetabolite therapeutic strategies for cancer treatments

 

Link to website: https://www.science.org/doi/10.1126/sciadv.abh2443

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Next-Generation Sequencing in Metastatic Breast Cancer: A Game Changer for Asian Patients

This study, led by N2CR members Dr Joline Lim and A/Prof David Tan, looks at the use of next-generation sequencing …

Read More →
Research News

Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

Cell cycle dysregulation, a key feature of cancer, leads to excessive cell division. CDK4 and CDK6 are essential for cell …

Read More →
Research News

Macrophage Signatures that Help Predict Lymphoma Patient’s Survival Rate

Macrophages are “big eaters” in our body; they are immune cells that engulf and kill invading organisms and cancer cells. …

Read More →